Düşük doğum tartılı bebeklerde enteral glutamin desteğinin kilo alma modelleri ve dışkıdaki salgısal immünoglubulin A düzeyleri üzerinde etkisi

Amaç: Glutamin optimal hücre çoğalması ve immün sistem için veözellikle bağırsaklarda bulunan enterositlerde mukozal immün yanıtlar için gereklidir. Düşük doğum ağırlığı, bebekleri glutamin eksikliğine karşı duyarlı kılar, çünkü yaşamın ilk haftası içinde beslenmekısıtlıdır. Bu çalışmanın amacı enteral glutamin desteğinin kilo almamodelleri ve dışkıdaki salgısal immünoglobulin A üzerindeki etkilerini belirlemektir.Gereç ve Yöntemler: Bu çalışma, çift-kör, randomize, kontrollü bir çalışmadır. Bebekler, randomize olarak glutamin grubuna ve plasebogrubuna ayrılmışlardır. Glutamin grubuna 14 gün süre ile 400 mg/kg/gün glutamin desteği verilmiştir ve plasebo grubuna 14 gün süre ile400 mg/kg/gün glükoz verilmiştir. Bebekler 30 gün süre ile gözlenmişlerdir. Çalışma esnasında, doğum ağırlığına geri dönüş, kilo almahızı ve dışkıdaki salgısal immünoglobulin A düzeyleri izlenmiştir.Bulgular: Otuz yedi düşük doğum ağırlıklı bebek randomize olarakglutamin ve plasebo gruplarına ayrılmışlardır. Glutamin grubunda,doğum ağırlığına geri dönme süresi daha kısa (8,1±0,9 vs. 11,0±1,6gün) ve kilo alma hızı daha yüksek (20,0±1,8 vs. 15,5±2,2 g/kg/gün) bulunmuştur (p

Effect of enteral glutamine supplementation for low-birth-weight infants on weight gain patterns and levels of fecal secretory immunoglobulin A

Aim: Glutamine is needed for optimal cell growth and for the immune system, especially in the enterocytes of gut mucosal immune responses. Low birth weight makes infants susceptible to glutamine depletion because nutrition is limited in the first week of life. To determine the effect of enteral glutamine supplementation on weight gain patterns and fecal secretory immunoglobulin A. Material and Methods: This study is a double-blind, randomized controlled trial. Infants were randomly assigned to the glutamine group and placebo group. The glutamine group was supplemented with glutamine 400 mg/kg/day for 14 days, and placebo group received glucose 400 mg/kg/day for 14 days. The infants were observed for 30 days. Return-to-birth-weight, weight gain velocity, and fecal secretory immunoglobulin A levels were monitored during the study. Results: Thirty-seven low-birth-weight infants were randomly assigned to the glutamine and placebo groups. The glutamine group had a shorter return-to-birth-weight time than the placebo group (8.1±0.9 vs. 11.0±1.6 days) and faster weight gain velocity (20.0±1.8 vs. 15.5±2.2 g/kg/day) (p

___

  • 1. Bang A, Deshmuk MD, Reddy MH. Child mortality in Maharashtra. Econ Polit Wkly 2002; 37: 4947-65.
  • 2. Department of Pediatric Faculty of Medicine Universitas Airlangga. Annual Report on Neonatology Division Department of Pediatric Faculty of Medicine Universitas Airlangga. Surabaya: Faculty of Medicine Universitas Airlangga, 2011.
  • 3. Adamkin DH. Feeding the preterm infant. In: Bhatia JB (ed). Perinatal nutrition: optimizing ınfant health and development. New York: Marcel Dekker, 2004.p. 165-90. [CrossRef]
  • 4. Adamkin DH. Enteral feeding guideline practicum. In: Adamkin DH, (ed). Nutritional strategies for the very low birth weight infant. New York: Cambridge University press, 2009.p. 107-15. [CrossRef]
  • 5. Sitohang NA. Asuhan Keperawatan Pada Bayi Berat Badan Lahir Rendah. Department of Nursing, Medan: Universitas Sumatra Utara, 2004.p. 22.
  • 6. Shulhan J, Dicken B, Hartling L, Larsen BM. current knowledge of necrotizing enterocolitis in preterm infants and the impact of different types of enteral nutrition products. Adv Nutr 2017; 8: 80-91. [CrossRef]
  • 7. Ray RM, Johnson LR. Regulation of intestinal mucosal growth by amino acids. Amino acids 2014; 46: 565-73. [CrossRef]
  • 8. Neu J, Roig JC, Meetze WH, et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr 1997; 131: 691-9. [CrossRef]
  • 9. Korkmaz A, Yurdakok M, Yigit S, Tekinalp G. Long-term enteral glutamine supplementation in very low birth weight infants: effects on growth parameters. Turk J Pediatr 2007; 49: 37-44.
  • 10. van den Berg A, van Zwol A, Moll HA, Fetter WP, van Elburg RM. Glutamine-enriched enteral nutrition in very low-birth-weight infants: effect on the incidence of allergic and infectious diseases in the first year of life. Arch Pediatr Adolesc Med 2007; 161: 1095-101. [CrossRef]
  • 11. Li ZH, Wang DH, Dong M. Effect of parenteral glutamine supplementation in premature infants. Chin Med J 2007; 120: 140-4. [CrossRef]
  • 12. Ren W, Wang K, Yin J, et al. Glutamine-induced secretion of intestinal secretory immunoglobulin A: A mechanistic perspective. Front Immunol 2016; 7: 503. [CrossRef]
  • 13. Agostoni C, Carratu B, Boniglia C, Riva E, Sanzini E. Free amino acid content in standard infant formulas: comparison with human milk. J Am Coll Nutr 2000; 19: 434-8. [CrossRef]
  • 14. Moe-Byrne T, Wagner JV, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012: CD001457. [CrossRef]
  • 15. Federer WT. Principles of statistical design with special reference to experiment and treatment design. New York: Cornell University, 1983.
  • 16. Darmaun D, Roig JC, Auestad N, Sager BK, Neu J. Glutamine metabolism in very low birth weight infants. Pediatr Res 1997; 41: 391-6. [CrossRef]
  • 17. Deirdre E, Diane Ml. Nutrition. In: Cloherty JP, Eichenwald EC, Stark AR (eds). Manual of Neonatal Care. 7 ed. Philadelphia: Lippincott William Wilkins, 2012.p. 114-36.
  • 18. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ 1998; 317: 1481-7. [CrossRef]
  • 19. Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev 2005; 206: 64-82. [CrossRef]
  • 20. Mayer L. Mucosal immunity. Immunol Rev 2005; 206: 5. [CrossRef]
  • 21. Khan J, Iiboshi Y, Cui L, et al. Alanyl-glutamine-supplemented parenteral nutrition increases luminal mucus gel and decreases permeability in the rat small intestine. JPEN 1999; 23: 24-31. [CrossRef]
  • 22. Mantis NJ, Rol N, Corthesy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 2011; 4: 603-11. [CrossRef]
  • 23. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium “The Intelligent Intestine,” held in Paris, June 14, 2002. Am J Clin Nutr 2003; 78: 675-83. [CrossRef]
  • 24. Corthesy B. Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol 2013; 4: 185. [CrossRef]